Get started
SERNOVA BIOTHERAPEUTICSSERNOVA BIOTHERAPEUTICSSERNOVA BIOTHERAPEUTICS

SERNOVA BIOTHERAPEUTICS

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast

PSH0 chart


Full chart

PSH0 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪39.55 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.060 EUR
Net income (FY)
‪−21.22 M‬ EUR
Revenue (FY)
0.00 EUR
Shares float
‪315.01 M‬
Beta (1Y)
−1.60

Employees


Employees (FY)
17
Change (1Y)
−9 −34.62%
Revenue / Employee (1Y)
0.00 EUR
Net income / Employee (1Y)
‪−1.25 M‬ EUR

About SERNOVA BIOTHERAPEUTICS INC


Sector
Health Technology
Industry
Biotechnology
CEO
Jonathan M. N. Rigby
Website
sernova.com
Headquarters
London
Founded
1998
FIGI
BBG000DWHHB6
Sernova Biotherapeutics Inc. is a clinical-stage biotechnology company, which engages in advancing regenerative medicine in the treatment of chronic diseases. It focuses on its proprietary Cell Pouch, a bio-hybrid organ system which is designed to enhance the delivery of cell therapy to better replicate natural body functions. The company was founded on August 19, 1998 and is headquartered in London, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

PSH0 news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Check out other big names from the same industry as PSH0.

Frequently Asked Questions


The current price of PSH0 is 0.124 EUR — it has decreased by −17.33% in the past 24 hours. Watch SERNOVA BIOTHERAPEUTICS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SERNOVA BIOTHERAPEUTICS stocks are traded under the ticker PSH0.
PSH0 stock has risen by 12.73% compared to the previous week, the month change is a 21.57% rise, over the last year SERNOVA BIOTHERAPEUTICS has showed a −5.49% decrease.
We've gathered analysts' opinions on SERNOVA BIOTHERAPEUTICS future price: according to them, PSH0 price has a max estimate of 3.80 EUR and a min estimate of 0.38 EUR. Watch PSH0 chart and read a more detailed SERNOVA BIOTHERAPEUTICS stock forecast: see what analysts think of SERNOVA BIOTHERAPEUTICS and suggest that you do with its stocks.
PSH0 reached its all-time high on Apr 24, 2025 with the price of 0.150 EUR, and its all-time low was 0.091 EUR and was reached on Mar 28, 2025. View more price dynamics on PSH0 chart.
See other stocks reaching their highest and lowest prices.
PSH0 stock is 20.97% volatile and has beta coefficient of −1.60. Track SERNOVA BIOTHERAPEUTICS stock price on the chart and check out the list of the most volatile stocks — is SERNOVA BIOTHERAPEUTICS there?
Today SERNOVA BIOTHERAPEUTICS has the market capitalization of ‪39.55 M‬, it has increased by 17.44% over the last week.
Yes, you can track SERNOVA BIOTHERAPEUTICS financials in yearly and quarterly reports right on TradingView.
SERNOVA BIOTHERAPEUTICS is going to release the next earnings report on Jun 25, 2025. Keep track of upcoming events with our Earnings Calendar.
PSH0 earnings for the last quarter are −0.012 EUR per share, whereas the estimation was −0.018 EUR resulting in a 36.30% surprise. The estimated earnings for the next quarter are −0.013 EUR per share. See more details about SERNOVA BIOTHERAPEUTICS earnings.
SERNOVA BIOTHERAPEUTICS revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
PSH0 net income for the last quarter is ‪−3.78 M‬ EUR, while the quarter before that showed ‪−3.28 M‬ EUR of net income which accounts for −15.52% change. Track more SERNOVA BIOTHERAPEUTICS financial stats to get the full picture.
No, PSH0 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 27, 2025, the company has 17 employees. See our rating of the largest employees — is SERNOVA BIOTHERAPEUTICS on this list?
Like other stocks, PSH0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SERNOVA BIOTHERAPEUTICS stock right from TradingView charts — choose your broker and connect to your account.